Patient-Centric Research: How Optimized Trials Enhance Patient Enrollment, Retention, and More

Life Sciences, Clinical Trials, Patient Recruitment & Retention, Drug Discovery & Development,
  • Tuesday, July 23, 2024 | 1pm EDT (10am PDT)
  • 60 min

Clinical research is not functioning optimally. It takes 7-13 years to develop a new drug, with 85% of trials missing their targeted timelines, most having less than 15% minority representation, and some having as high as a 30% dropout rate.1 The industry has tried several approaches to mitigate these problems, one of the most recent being decentralized clinical trials (DCTs). Trials with decentralized elements — coined “optimized trials” — do help with common research challenges, evidenced by their widespread, growing adoption.2,3 Why? Because they prioritize accessing the patient in the right location at the right time to expand access.

Join the Elligo Elite Learning Series presentation “Patient-Centric Research: How Optimized Trials Enhance Patient Enrollment, Retention, and More” for an in-depth discussion of optimized trials and how they lead to more efficiency and successful patient enrollment, retention, and diversity. The roundtable will feature Elligo Health Research® experts Barry Simms, CEO; Dr. Faith Holmes, Chief Medical Officer: Jacylyn Dougherty, Chief Product & Technology Officer; and Leslie Carney, Senior Director, Patient Support Recruitment & Marketing. The panelists will introduce the concept of optimized trials, offering detailed explanations of the benefits of using a mix of DCT elements and traditional sites as well as research technology and centralized oversight. They will also dig into the importance of the trusted patient–physician relationship in both healthcare and research, explaining how optimized trials harness this relationship to accelerate the development of new medicines and therapies. Finally, the experts will walk through the possible challenges of running an optimized or virtual-first trial, from managing technology to patient recruitment and recent feedback from FDA, and provide solutions for each that have been proven in real-world research.

Optimized trials are the best way to solve research’s biggest challenges, but only if we take advantage of them. Get the information you need to implement these new techniques in the Elligo Elite Learning Series presentation “Patient-Centric Research: How Optimized Trials Enhance Patient Enrollment, Retention, and More.”


Only Elligo. Elligo Health Research. Accessed 2024 May 28.

Nov 2020 DCT Survey Report. PPD. Accessed 2024 May 28.

Nov 2023 Pulse Report. PPD. Accessed 2024 May 28.


Barry Simms, Elligo Health Research®

Barry Simms, CEO, Elligo Health Research®

With over 22 years of experience in clinical research and pharmaceutical services, Barry Simms has dedicated his career to advancing the development of novel therapeutics through expert organizational leadership. His executive management skills are showcased in his oversight of large-scale operations including project management, clinical kitting, accessioning and biorepository for companies with more than 700 employees.

His notable proficiency in business development is exemplified in his experience with high-growth, private equity-owned organizations, oversight of global laboratory partnership programs and work enhancing operational efficiency, productivity and consistency with private equity owners and Boards of Directors.


Prior to Elligo, Simms was Chief Operating Officer and Interim CEO at LabConnect, and a Senior Executive for several research organizations. He earned a BS in Accounting from the University of Virginia at Wise and an MBA from King University. He has also received several accolades, including an Outstanding Achievement in Accounting Award and placement on the Executive Steering Committee of PharmaTimes.

Read Less...

Message Presenter
Jacylyn Dougherty, Elligo Health Research®

Jacylyn Dougherty, Chief Product Officer, Elligo Health Research®

Jacylyn Dougherty has more than 25 years of progressive product, technology and digital transformation experience in the life sciences industry. As Elligo’s Chief Product Officer, she is responsible for product strategy and delivery in support of Elligo’s tech-enabled service model.

Powered by her passion for delivering unique value to customers and enabling transformation in clinical trial conduct, she manages a team that includes product managers, engineers, UX designers, product support and implementation specialists that developed and continually improve Elligo’s proprietary IntElligo® Research Stack and Study Marketplace technology.

Message Presenter
Leslie Carney, Elligo Health Research®

Leslie Carney, Patient Support Recruitment & Marketing, Elligo Health Research®

Leslie Carney, MBA, has over 20 years of consumer marketing, relationship management, and sales experience, having started in the nonprofit sector as a fundraiser before joining clinical research in 2017. Leslie joined Elligo in 2024 as Senior Director, Patient Solutions, and is leading the company’s initiative to maximize internal resources, align with strategic partners where needed, and infuse patient centricity into Elligo’s comprehensive efforts engaging with patients and sites to accelerate enrollment.


Prior to Elligo, Leslie was with CVS Clinical Trial Services, where she oversaw enrollment for a fully virtual asthma study and managed local, community-based recruitment for CVS Trial Delivery sites. She has managed recruitment for U.S. sites as well as OUS projects directly for clients, focusing on digital marketing and partnerships to ensure high-volume and rapid enrollment goals are achieved. During her time at IQVIA, Leslie developed bespoke recruitment and retention strategies to remove barriers to enrollment and reduce burden on patients and sites for traditional site models as well as hybrid and fully virtual study designs.

Read Less...

Message Presenter
Dr. Faith Holmes, Elligo Health Research®

Dr. Faith Holmes, Chief Medical Officer, Elligo Health Research®

Dr. Faith Holmes brings more than 30 years of experience in direct patient care and 11 years of medical practice management for her role as Elligo’s Chief Medical Officer. Her unique perspective plays an important part in building the company’s network of Research Ready physician practices and preparing them to conduct research.

Holmes’ rich perspective — including experience in family medicine, hospice, and palliative medicine that spans solo practice and single specialty and multispecialty group practices — allows her to build rapport with study managers, site staff and investigators, and provide medical and scientific knowledge to support future growth.


Holmes has served as the Principal Investigator for interventional, diagnostic device and observational trials in several therapeutic indications in Elligo’s eSolutions model and at the Elligo Clinical Research Center. She earned her BS in Chemistry and Biology from Trevecca University, her MD from ORU School of Medicine, and is board-certified in Family Medicine and Hospice and Palliative Medicine.

Read Less...

Message Presenter

Who Should Attend?

This webinar will appeal to professionals in the following fields:

  • Pharma
  • Biotech and medical device with a focus on cardiology
  • Endocrinology
  • Internal Medicine
  • Psychiatry
  • Pulmonology
  • Neurology

What You Will Learn

Attendees will learn about:

  • What optimized trials are
  • The advantages of this trial model for modern clinical research
  • The importance of centralized oversight and technology in optimized trials
  • Expert tips for implementing optimized trials

Xtalks Partner

Elligo Health Research

Elligo Health Research accelerates clinical trials through EHR data, our proprietary IntElligo® technology, and direct access to known, diverse patients from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites. Our PatientSelect® model engages our network of networks to optimize the intersection of healthcare and research and bring more patients clinical research as a care option. Our SiteSelect model and Research Partner Services enable sites to seamlessly participate in trials, further advancing the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account